Legal Representation
Attorney
/Arnold Braun/
USPTO Deadlines
Application History
35 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 1, 2023 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Sep 1, 2023 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Sep 1, 2023 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| May 18, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 18, 2023 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| May 18, 2023 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
| Apr 24, 2023 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Apr 4, 2023 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Apr 24, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Apr 4, 2023 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Sep 16, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 14, 2022 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Sep 14, 2022 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Sep 14, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 2, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 31, 2022 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| May 31, 2022 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| May 31, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 24, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 22, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Nov 22, 2021 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Nov 22, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 8, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 13, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 13, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 24, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 9, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 9, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Mar 9, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 9, 2021 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 9, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Mar 5, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 21, 2020 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Nov 20, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 10, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 044
Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical testing for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of Cancer
First Use Anywhere:
20201100
First Use in Commerce:
20201100
Additional Information
Design Mark
The mark consists of the word "IMMUNOVEDA" in purple, above the letter "I" is a purple dot; starting from this first dot is series of gradient purple to blue dots with each dot getting smaller in size and lighter in contrast to the first dot, and the space between the dots increases as the dots sweep upward in a curve toward the top of the mark, creating a band of dots, reaching an apex whereupon they descend in a curve toward the letter "A", upon reaching the letter "A" in one single dot whereupon they end. The color white represents background and transparent areas and is not part of the mark.
Color Claim
The colors blue and purple are claimed as a feature of the mark.
Classification
International Classes
044